Search Results - "Kudlacek, Stefan"

Refine Results
  1. 1

    Myostatin and markers of bone metabolism in dermatomyositis by Kerschan-Schindl, Katharina, Gruther, Wolfgang, Föger-Samwald, Ursula, Bangert, Christine, Kudlacek, Stefan, Pietschmann, Peter

    Published in BMC musculoskeletal disorders (05-02-2021)
    “…In dermatomyostis (DM) patients, inflammation, reduced activity, and medication have a negative impact on the musculoskeletal system. Several endocrine factors…”
    Get full text
    Journal Article
  2. 2

    Low Bone Mineral Density and Fragility Fractures in Permanent Vegetative State Patients by Oppl, Bastian, Michitsch, Gabriele, Misof, Barbara, Kudlacek, Stefan, Donis, Johann, Klaushofer, Klaus, Zwerina, Jochen, Zwettler, Elisabeth

    Published in Journal of bone and mineral research (01-05-2014)
    “…ABSTRACT Disuse of the musculoskeletal system causes bone loss. Whether patients in vegetative state, a dramatic example of immobilization after severe brain…”
    Get full text
    Journal Article
  3. 3

    Serum levels of sclerostin and dickkopf-1: effects of age, gender and fracture status by Dovjak, Peter, Dorfer, Sonja, Föger-Samwald, Ursula, Kudlacek, Stefan, Marculescu, Rodrig, Pietschmann, Peter

    Published in Gerontology (Basel) (01-01-2014)
    “…Fragility fractures, especially hip fractures, are a very common complication of osteoporosis in elderly subjects. Sclerostin (SOST) and dickkopf-1 (DKK-1) are…”
    Get more information
    Journal Article
  4. 4

    Lactose intolerance: a risk factor for reduced bone mineral density and vertebral fractures? by Kudlacek, Stefan, Freudenthaler, Othmar, Weissböeck, Hannelore, Schneider, Barbara, Willvonseder, Robert

    Published in Journal of gastroenterology (01-12-2002)
    “…The purpose of the present study was to determine differences, if any, in bone mineral density, the risk of fracture, and clinical behavior in patients with…”
    Get full text
    Journal Article
  5. 5

    Surface markers and transendothelial migration of dendritic cells from elderly subjects by Pietschmann, Peter, Hahn, Philipp, Kudlacek, Stefan, Thomas, Ranjeny, Peterlik, Meinrad

    Published in Experimental gerontology (01-03-2000)
    “…Age-related changes of immune functions have been extensively investigated in both humans and animal models; nevertheless, the literature on potential…”
    Get full text
    Journal Article
  6. 6

    Bisphosphonate Treatment does not Affect Serum Levels of Osteoprotegerin and RANKL in Hypercalcemic Cancer Patients by ZOJER, Niklas, BRENNER, Karin, BEKE, Dora, KUDLACEK, Stefan, HAWA, Gerhard, WOLOSZCZUK, Wolfgang, HOFBAUER, Lorenz C, PECHERSTORFER, Martin

    Published in Anticancer research (01-09-2005)
    “…Bisphosphonates are the standard treatment for hypercalcemia of malignancy. We hypothesized that bisphosphonate treatment and the subsequent fall in serum…”
    Get full text
    Journal Article
  7. 7

    Circulating bioactive sclerostin levels in an Austrian population-based cohort by Kerschan-Schindl, Katharina, Föger-Samwald, Ursula, Gleiss, Andreas, Kudlacek, Stefan, Wallwitz, Jacqueline, Pietschmann, Peter

    Published in Wiener Klinische Wochenschrift (01-01-2022)
    “…Summary Background Circulating serum sclerostin levels are supposed to give a good estimation of the levels of this negative regulator of bone mass within…”
    Get full text
    Journal Article
  8. 8

    Influence of age and gender on associations of body mass index with bone mineral density, bone turnover markers and circulating calcium-regulating and bone-active sex hormones by Puntus, Thomas, Schneider, Barbara, Meran, Johannes, Peterlik, Meinrad, Kudlacek, Stefan

    Published in Bone (New York, N.Y.) (01-10-2011)
    “…Abstract Although it is well known that body mass index (BMI) and bone mineral density (BMD) are positively correlated, the mechanisms by which adiposity…”
    Get full text
    Journal Article
  9. 9

    Osteoprotegerin plasma concentrations correlate with severity of peripheral artery disease by Ziegler, Sophie, Kudlacek, Stefan, Luger, Anton, Minar, Erich

    Published in Atherosclerosis (01-09-2005)
    “…Osteoprotegerin (OPG), a member of the tumor necrosis factor receptor family, is involved in the process of bone turnover and also in the pathogenesis of…”
    Get full text
    Journal Article
  10. 10

    Osteoporosis in men receiving androgen deprivation therapy for non-metastatic prostate cancer by Kudlacek, Stefan, Puntus, Thomas

    Published in Wiener medizinische Wochenschrift (01-09-2012)
    “…Osteoporosis is defined as a continuous loss of bone mineral density accompanied by an increased fracture risk in females and males. A fall of estrogen…”
    Get full text
    Journal Article
  11. 11

    Neoadjuvant Chemotherapy with Gemcitabine plus Cisplatin in Patients with Locally Advanced Bladder Cancer by Niedersüss-Beke, Dora, Puntus, Thomas, Kunit, Thomas, Grünberger, Birgit, Lamche, Michael, Loidl, Wolfgang, Böhm, Reinhard, Kraischits, Nicole, Kudlacek, Stefan, Schramek, Paul, Meran, Johannes G

    Published in Oncology (01-01-2017)
    “…Neoadjuvant chemotherapy with methotrexate-vinblastine-doxorubicin-cisplatin (MVAC) is the standard of care for muscle-invasive urothelial bladder cancer…”
    Get more information
    Journal Article
  12. 12

    Myostatin and other musculoskeletal markers in lung transplant recipients by Kerschan-Schindl, Katharina, Ebenbichler, Gerold, Gruther, Wolfgang, Föger-Samwald, Ursula, Kudlacek, Stefan, Patsch, Janina, Gleiss, Andreas, Jaksch, Peter, Klepetko, Walter, Pietschmann, Peter

    Published in Clinical and experimental medicine (01-02-2019)
    “…Recipients of lung transplantation (LuTx) may experience impaired muscle function and bone metabolism even after rehabilitation. We investigated the potential…”
    Get full text
    Journal Article
  13. 13

    Biomarkers of bone turnover in diagnosis and therapy of osteoporosis: A consensus advice from an Austrian working group by Bieglmayer, Christian, Dimai, Hans Peter, Gasser, Rudolf Wolfgang, Kudlacek, Stefan, Obermayer-Pietsch, Barbara, Woloszczuk, Wolfgang, Zwettler, Elisabeth, Griesmacher, Andrea

    Published in Wiener medizinische Wochenschrift (01-11-2012)
    “…Summary Aim Reasonable application of laboratory parameters in prevention, diagnosis, treatment and therapy monitoring of osteoporosis. Target groups…”
    Get full text
    Journal Article Conference Proceeding
  14. 14

    Osteoporose beim Mann mit hormonablativer Therapie bei nicht-metastasiertem Prostatakarzinom by Kudlacek, Stefan, Puntus, Thomas

    Published in Wiener medizinische Wochenschrift (01-09-2012)
    “…Zusammenfassung Die Osteoporose als ein systemischer Verlust des Knochenmineralgehaltes mit erhöhter Frakturinzidenz wurde bisher überwiegend bei Frauen…”
    Get full text
    Journal Article
  15. 15

    Case report of a patient with renal cell cancer and his fateful progress - Breaking Bad News by Kudlacek, Stefan, Meran, Johannes G

    Published in Wiener medizinische Wochenschrift (01-01-2012)
    “…"Breaking Bad News" outlines a pathway for medical and other professional staff to deliver bad news to patients, clients, their families and carers. Bad news…”
    Get full text
    Journal Article
  16. 16

    Assessment of vitamin D and calcium status in healthy adult Austrians by Kudlacek, S., Schneider, B., Peterlik, M., Leb, G., Klaushofer, K., Weber, K., Woloszczuk, W., Willvonseder, R.

    Published in European journal of clinical investigation (01-04-2003)
    “…Background Because there is reason to assume that also in Austria calcium and vitamin D malnutrition is wide‐spread, we initiated a comprehensive study on…”
    Get full text
    Journal Article
  17. 17

    Update on denosumab in postmenopausal osteoporosis—recent clinical data by Muschitz, Christian, Fahrleitner-Pammer, Astrid, Huber, Johannes, Preisinger, Elisabeth, Kudlacek, Stefan, Resch, Heinrich

    Published in Wiener medizinische Wochenschrift (01-09-2012)
    “…Summary Denosumab, a fully human monoclonal antibody against the key osteoclastogenic factor RANK ligand, is currently approved for the treatment of…”
    Get full text
    Journal Article
  18. 18
  19. 19

    High cathepsin K levels in men with differentiated thyroid cancer on suppressive L-thyroxine therapy by Mikosch, Peter, Kerschan-Schindl, Katharina, Woloszczuk, Wolfgang, Stettner, Haro, Kudlacek, Stefan, Kresnik, Ewald, Gallowitsch, Hans J, Lind, Peter, Pietschmann, Peter

    Published in Thyroid (New York, N.Y.) (01-01-2008)
    “…Thyroid hormone administration is associated with low bone density in some studies. The aim of the present study was to evaluate the influence L-thyroxine, in…”
    Get more information
    Journal Article
  20. 20

    Ein Patient mit schicksalhaftem Verlauf nach Nephrektomie bei Hypernephrom Überbringen schlechter Nachrichten (Braking Bad News) by Kudlacek, Stefan, Meran, Johannes G.

    Published in Wiener medizinische Wochenschrift (2012)
    “…Zusammenfassung Das Patientengespräch hat einen wesentlichen Stellenwert im medizinischen Alltag eingenommen. Patienten möchten über Diagnosen und Prognosen…”
    Get full text
    Journal Article